Table 1.
Vaccine | Type | Safe pre-transplant1 | Safe post-transplant | Clinical response monitoring |
---|---|---|---|---|
Influenzaa | I (intradermal) | Yes | Yes | No |
Influenza | LAIV (intranasal) | Yes | No | No |
Hepatitis Bb | I | Yes | Yes | Yes |
Hepatitis A | I | Yes | Yes | Yes |
Tetanus/diphtheria | I | Yes | Yes | No |
Pertussis | I | Yes | Yes | No |
Measles, mumps, rubella | LAIV | Yes | No | Yes |
Varicella | LAIV | Yes | No | Yes |
Zoster (Zostavax)c |
LAIV | Yes | No | No |
Zoster (Shingrix)c |
I | Yes | -- | No |
Pneumococcal (PCV13) |
I | Yes | Yes | No |
Pneumococcal (PPSV23) |
I | Yes | Yes | No |
Meningococcus | I | Yes | Yes | No |
Human papillomavirus virus | I | Yes | Yes | No |
Poliod (IPV) |
I | Yes | Yes | No |
Haemophilus influenza | I | Yes | Yes | No |
Rabies | I | Yes | Yes | Yes |
Typhoid ViCPS (Typhim Vi, Sanofi Pasteur) |
I (intradermal) |
Yes | Yes | No |
Typhoid Ty21a (Vivotif, Swiss PaxVax) |
LAIV (oral) |
Yes | No | No |
Cholera | LAIV | Yes | No | No |
Japanese encephalitis | I | Yes | Yes | No |
Yellow fever | LAIV | Yes | No | No |
I, inactivated vaccine; LAIV, live attenuated vaccine
1When indicated vaccination series are preferred to be completed prior to transplantation to increase efficacy
aInfluenza higher dose influenza vaccination should be considered for transplant recipients
bHepatitis B vaccine both HD patients and KT patients should receive the higher dose vaccine at 40 mcg of HBV surface antigen for Recombivax HB or Engerix-B
cShingrix is the preferred Zoster vaccine per ACIP recommendation
dPolio IPV only polio vaccine licensed for adults available in the USA